Clarra Introduces the Most Comprehensive MCP Server for Legal Case Management
Enables Law Firms and Legal Departments to Fully Leverage Claude Cowork to Transform Legal Work and Eliminate the Need for AI Point Solutions
"Legal teams shouldn't have to purchase a different AI application for every task," said
Through the integration, legal teams can combine Claude's 12 legal practice-area plugins and 90 specialized agents with Clarra matter data, documents, notes, deadlines, resources, accounting information, and workflows to:
- Generate litigation briefs, matter summaries, chronologies, and demand letters
- Analyze deposition transcripts, medical records, and other case materials
- Prepare case strategies, deposition outlines, and litigation analyses
- Create staffing, budgeting, billing, dashboards, and board reporting using live Clarra matter data
- Update matters, create tasks, and configure workflows within Clarra using agentic AI
"We wanted to meet legal teams where their data already lives without compromising security to get there," said
Unlike standalone AI assistants and AI point solutions that require users to manually upload documents or work across disconnected applications, Clarra's MCP integration enables Claude to securely access litigation data already managed within Clarra. Because Clarra provides the structured context, Claude can better understand how that data relates and use it more effectively. Combined with Claude's extensive legal skills and plugins, organizations can perform a wide range of litigation AI tasks from a single source of truth.
"For litigators, the real value of AI comes when it can work with the full context of a matter and fit into the way attorneys already practice," said
The Claude Cowork integration is part of Clarra's broader AI strategy to combine litigation management, workflow automation, analytics, and AI in a single cloud-based platform. Clarra's MCP Server provides token-efficient access to more than 250 REST API endpoints, while giving administrators the flexibility to configure custom properties and tailor the platform to firm-specific workflows. Beyond Claude, users can connect Clarra to ChatGPT, Microsoft Copilot, Cursor, and Lovable to build applications, portals, dashboards, intake systems, and other AI-powered workflows on top of Clarra.
"What Clarra is doing reflects where the next generation of legal technology is headed. The future is a strong, secure system of record underneath, with the flexibility to vibe code, customize and build the experience on top of it," said
The announcement follows continued momentum for Clarra's platform expansion, including recent integrations with NetDocuments, iManage,
Clarra will demonstrate AI workflows and its MCP server at ILTACON 2026 at Booth #816.
For more information, visit clarra.com or schedule a demo.
About Clarra
Clarra is a software-as-a-service (SaaS) company founded in 2021 that provides a cloud-based case and legal practice management platform optimized for litigation. Designed for law firms, enterprise legal departments, and insurance, finance and services teams, Clarra brings matter and case information into a single, cloud-based system that supports collaboration, tracking and oversight across the full lifecycle of a matter. With generative and agentic AI capabilities, broad integration support, no-code customization, and built-in analytics delivered through a simple, intuitive user interface, Clarra helps organizations improve efficiency and visibility to support better business outcomes. For more information, visit www.clarra.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarra-introduces-the-most-comprehensive-mcp-server-for-legal-case-management-302854675.html
SOURCE Clarra, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
- AsenseAI vs AlphaPepe: Top Crypto Presale To Invest In? AlphaPepe Stage 20 Momentum Makes the Higher-Traction AI Bet
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share